In this study, at the first time, we performed in vivo kex MRI of MS patients and evaluated its potential value for staging clinical MS lesions. In vivo proton exchange rate mapping was found to be highly correlated with Gadolinium enhancement for determining lesion activity. With further validation, kex may be an alternative endogenous MRI contrast for the clinical determination of dissemination in time (DIT) of MS lesions.
This abstract and the presentation materials are available to members only; a login is required.